Table 2.

Proteinuria evolution.

Period	Entire cohort (± SD)	Baseline proteinuria < 2 g/d (± SD)	Baseline proteinuria 2–3.5 g/d (± SD)	Baseline proteinuria > 3.5 g/d (± SD)	Baseline eGFR < 60ml/min (± SD)	Baseline eGFR ≥ 60ml/min (± SD)
Baseline	1.89 ± 1.5	1.17 ± 0.34	2.51 ± 0.4	4.22 ± 1.18	1.83 ± 1.31	1.94 ± 1.07
3 mo	1.22 ± 0.85	0.78 ± 0.41	1.55 ± 1.39	2.75 ± 0.99	1.23 ± 0.59	1.2 ± 1.03
6 mo	1.2 ± 0.98	0.78 ± 0.55	1.65 ± 1.01	2.39 ± 1.43	1.34 ± 0.85	1.07 ± 1.09
12 mo	1.19 ± 1.17	0.87 ± 0.84	1.12 ± 0.7	2.89 ± 2.03	1.18 ± 0.85	1.19 ± 1.43
15 mo	0.9 ± 0.7	0.72 ± 0.61	1.19 ± 0.81	1.35 ± 0.71	1 ± 0.71	0.81 ± 0.7
18 mo	0.96 ± 1.07	0.72 ± 0.76	1.14 ± 0.97	1.87 ± 2.12	1.11 ± 0.89	0.83 ± 1.22
24 mo	0.76 ± 0.72	0.67 ± 0.76	0.91 ± 0.69	0.92 ± 0.65	0.97 ± 0.77	0.55 ± 0.62
36 mo	0.5 ± 0.4	0.39 ± 0.39	0.82 ± 0.15	0.74 ± 0.42	0.53 ± 0.42	0.46 ± 0.4
Percentage reduction (95%CI)
12 mo	− 32.9% (− 53.6, − 12.2)	− 26.4% (− 57, 4.2)	− 54.7% (− 77.8, − 31.5)	− 22.1% (− 100, − 72.6)	− 19.5% (− 56, 16.9)	− 44.7% (− 69.2, − 20.2)
24 mo	− 49.7% (− 70.1, − 29.4)	− 42.2% (− 73.5, − 10.9)	− 55.4% (− 84.1, − 26.6)	− 76.1% (− 100, − 45.2)	− 29.2% (− 69.1, 10.6)	− 67.9% (− 83, − 52.8)
36 mo	− 68.1% (− 80.6, − 55.7)	− 65.6% (− 83.2, − 48)	− 65.2% (− 79.9, − 50.4)	− 81.2% (− 100, − 60.8)	− 59.1% (− 83.2, − 35.1)	− 77.2% (− 86.4, − 67.9)

eGFR estimated glomerular filtration rate, mo months, SD standard deviation, CI confidence interval.